Community perceptions and willingness to donate biospecimen for Alzheimer's disease research in Nairobi, Kenya
- 12 November 2025
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 108 (4) , 1537-1548
Abstract
Background: Biomarkers play a critical role in understanding disease mechanisms and advancing diagnostic and treatment options for Alzheimer's disease and related dementias (AD/ADRD). However, in many African countries, biomarker research is limited by insufficient knowledge, infrastructure, funding, and trained personnel. Objective: This study explored community perceptions and willingness to donate biospecimens for AD/ADRD research in Kenya. Methods: Eight focus group discussions were conducted in the informal settlements of Mathare and Kibera in Nairobi, Kenya, stratified by age and gender (n = 81). Data were transcribed verbatim and thematically analyzed using QSR Nvivo 14. Results: Participants generally expressed a positive attitude toward brain health research and donating biospecimens. Willingness to participate was influenced by altruism, perceived benefits, and improved understanding of AD/ADRD. Non-invasive samples such as saliva, blood, and stool were widely accepted due to perceptions of safety and familiarity. However, several barriers were identified, including cultural beliefs (e.g., fear of witchcraft linked to donating hair), religious beliefs, fear of invasive procedures (spinal taps), and low awareness about biospecimen research. To address these barriers, participants recommended community sensitization, inclusive and transparent research processes, clear communication of benefits, involvement of family members in consenting, and assurance of safety measures for managing potential risks. Conclusions: Community willingness to donate biospecimens for AD/ADRD research in Kenya is shaped by a complex interplay of cultural, ethical, and practical considerations. Culturally sensitive, community-driven approaches are essential to enhance participation in AD/ADRD biomarker research in Kenya and similar low-resource settings.Keywords
Funding Information
- This project was funded by the Davos Alzheimer's Collaborative, to the Brain and Mind Institute, Aga Khan University, Nairobi Kenya. (K5252)
This publication has 26 references indexed in Scilit:
- Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscapeNeuron, 2023
- Forecasting the prevalence of dementiaThe Lancet Public Health, 2022
- A Review of Regulatory Frameworks Governing Biobanking in the Low and Middle Income Member Countries of BCNetBiopreservation and Biobanking, 2021
- Basic principles of biobanking: from biological samples to precision medicine for patientsVirchows Archiv, 2021
- Patients' Knowledge and Attitude Toward Biobanks in Eastern MoroccoBiopreservation and Biobanking, 2020
- Brain banking in low and middle-income countries: Raison D'être for the Ibadan Brain Ageing, Dementia And Neurodegeneration (IBADAN) Brain Bank ProjectBrain Research Bulletin, 2019
- Biobanking in a Challenging African Environment: Unique Experience from the SIREN ProjectBiopreservation and Biobanking, 2018
- Developments in biospecimen researchBritish Medical Bulletin, 2015
- Introduction Knowledge translation: What it is and what it isn't2013
- Community-Based Partnership to Identify Keys to Biospecimen Research ParticipationJournal of Cancer Education, 2012